SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Corporate Action-Board approves Dividend
Recommended Final Dividend of Rs. 5 per share22-05-2024
22-05-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Board Meeting Outcome for Audited Financial Results And Dividend
Outcome of Board meeting22-05-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Loss of Share Certificate21-05-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding issuance of Letter of Confirmation in lieu of duplicate share certificate.15-05-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Press Release relating to Earnings Call for financial results for the fourth quarter and full year ended March 31, 202413-05-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Board Meeting Intimation for Audited Financial Results And Final Dividend
SUN PHARMACEUTICAL INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2024 ,inter alia, to consider and approve 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024. 2. Recommendation of final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2024, for approval of the shareholders at the ensuing Annual General Meeting.13-05-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regulatory Order
Intimation regarding regulatory order passed by GST Authority08-05-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation regarding Loss of Share Certificate08-05-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Announcement under Regulation 30 (LODR)-Acquisition
Intimation regarding acquisition04-05-2024
SUN PHARMACEUTICAL INDUSTRIES LTD. - 524715 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Regulatory Order
Intimation regarding order passed by Statutory Authority.30-04-2024